Concepedia

Yuji Masuta

YM

6

Publications

172

Citations

6

H-Index

2017

Active since

Affiliations

National Institute of Biomedical Innovation, Health and Nutrition(Current)

The University of Osaka

Osaka International University

VLP Therapeutics (United States)

National Hospital Organization

Yuji Masuta is an author at National Institute of Biomedical Innovation, Health and Nutrition specializing in immunodominance, t cell immunity, and immunoengineering.

ORCID

Top concepts

Publications per year

2017–2023

6

Publications

6

CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8+ T Cell Responses

Tomohiro Kanuma, Takuya Yamamoto, Kouji Kobiyama et al. · The Journal of Immunology · 2017 · 67 citations

Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study

Wataru Akahata, Takashi Sekida, Takuto Nogimori et al. · Cell Reports Medicine · 2023 · 33 citations · Full text

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern

Mai Komori, Takuto Nogimori, Amber L. Morey et al. · Nature Communications · 2023 · 32 citations · Full text

A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection

Takuya Yamamoto, Yuji Masuta, Masatoshi Momota et al. · International Immunology · 2018 · 15 citations · Full text

, , +18

Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination

Takuto Nogimori, Koichiro Suzuki, Yuji Masuta et al. · Frontiers in Immunology · 2023 · 14 citations · Full text

Rows per page

1–5 of 6